Abstract:IntroductionDepression, sleep disturbances, and cognitive deficits often co-occur. Compared to non-medicated controls, people using antidepressant medications (particularly serotonin agonists) often have improved sleep including increased slow wave sleep, quality and continuity. Improvements to cognition after antidepressant treatments are also common including benefits to reaction time, inhibition, and memory. Importantly, circadian deficits, including sleep onset latency, fragmentation, and phase shifts are common in patients with depression, yet the effect of antidepressant medication on circadian indicators is unclear. The current project examined sleep, circadian entrainment, and cognition in college students who were diagnosed with depression and using serotonin agonists and in those without depressive symptoms.MethodsParticipants completed cognitive tasks that assessed reaction time, memory, attention, inhibition, and logical reasoning via the Automated Neuropsychological Assessment Metric between 1100-1700 two times, first at study enrollment and second after a two-week study interval. After initial cognitive assessments, participants wore actigraphs for two weeks from which we extracted their sleep-wake patterns, total sleep time(TST), time in bed(TIB), sleep-onset latency(SOL), sleep efficiency, and wake after sleep onset(WASO). Study 1 included 15 undergraduate students (11F, 7 antidepressant users, Mage=19.53) and Study 2 included 25 graduate students (21F, 13 antidepressant users, Mage=25.37), all recruited from James Madison University.ResultsStudy 1 found that undergraduate antidepressant users had longer TIB, TST, and SOL. No cognitive or entrainment differences were found between drug use conditions. Within the antidepressant group, higher dosage predicted shorter TIB(r2=.64, p<.05), poorer spatial processing speed(r2=.73, p<.05) and logical relation performance(r2=.81, p<.05). In study 2, no circadian or cognitive differences were present across drug conditions. Deficits in WASO and sleep efficiency for antidepressant users were present. Within the antidepressant group, years of antidepressant use and dosage predicted poorer reaction time(r2=.84, p<.05), inhibition(r2=.70, p<.05), and spatial processing(r2=.98, p<.05). Self-reported wake episodes also predicted poorer reaction time and inhibition. Years of antidepressant use, dosage, and time of antidepressant use predicted TIB(r2=.73, p<.05), and time of antidepressant use predicted TST(sr2=.79, p<.05).ConclusionFuture studies should use longitudinal research designs and prospective methods to examine the impact of antidepressant medications on circadian rhythms, sleep and cognition.Support (If Any)

Mid-term effects of serial sleep deprivation therapy implemented in cognitive-behavioral treatment on the neuroendocrine response to clomipramine in patients with major depression

Local and Transient Changes of Sleep Spindle Density During Series of Prefrontal Repetitive Transcranial Magnetic Stimulation in Patients With a Major Depressive Episode

Effect of Repetitive Transcranial Magnetic Stimulation on the Cognitive Impairment Induced by Sleep Deprivation: a Randomized Trial.

0199 Effects of acute sleep deprivation on cognitive performance in depressed individuals

Longitudinal transcriptome-wide gene expression analysis of sleep deprivation treatment shows involvement of circadian genes and immune pathways

Neurophysiological Effects of Sleep Deprivation in Healthy Adults, a Pilot Study

Therapeutic sleep deprivation for major depressive disorder: A randomized controlled trial

Subclinical hypomanic experiences in young adults after sleep deprivation are independent of depressive disorders, chronotype or 5-HTTLPR polymorphism

0213 Circadian Entrainment and Cognition in College Students using Antidepressants

No Influence of a functional polymorphism within the serotonin transporter gene on partial sleep deprivation in major depression

Long-term effectiveness of a short-term cognitive-behavioral group treatment for primary insomnia

0396 Intensive Sleep Retraining and Sleep Deprivation for Treating Chronic Insomnia: A Randomized Controlled Trial

Clomipramine-induced serum prolactin as a marker for serotonin and dopamine turnover: results of an open label study

Multiplex influences on vigilance and biochemical variables induced by sleep deprivation

The influence of physical activity during sleep deprivation on mood and reaction speed to visual and auditory stimuli

Diurnal Alterations in Circadian Genes and Peptides in Major Depressive Disorder Before and after Escitalopram Treatment.

Changes of cortical excitability as markers of antidepressant response in bipolar depression: preliminary data obtained by combining transcranial magnetic stimulation (TMS) and electroencephalography (EEG)

Effect of Duloxetine on Cognitive Function and Neuroendocrine in Patients with Depression

Differential Effects of Citalopram on Sleep-Deprivation-induced Depressive-Like Behavior and Memory Impairments in Mice

Poster #95 IS CLOZAPINE TREATMENT ASSOCIATED WITH LOWER MORTALITY RATES IN SCHIZOPHRENIA? PRELIMINARY EVIDENCE FROM A REGISTER BASED STUDY

Acute 2-phenyl-3-(phenylselanyl)benzofuran treatment reverses the neurobehavioral alterations induced by sleep deprivation in mice